Clinical Trials

As of January 31, 2022, the EU has implemented the Regulation 2014/536 on clinical trials for Medicinal Products (MPs) intended for human use. This regulation provides a centralized approach for electronic submission and evaluation of clinical trials. Alongside this,...

Decentralized clinical trials (DCTs) can be considered to be the future of the industry due to the benefits they provide to drug developers and patients and their growing popularity. These benefits include ease for patients to participate in trials...

US Food and Drug Administration has come up with a novel draft guidance in order to further support the use of decentralised clinical trials when it comes to drugs, biologics, and devices. The publication has in it recommendations from...

UK scientists have gone on to conduct the first ever trial of a new drug for Alzheimer’s that is able to safely as well as successfully lower the levels of the very harmful tau protein, which is known to...

The University of Birmingham in the UK has entered into a collaboration with Dexter and Cagedim Health Data in order to conduct the RADIANT trial, which focuses on gestational diabetes mellitus. The trial will make use of a new approach...

ANGLE plc, one of the world-leading liquid biopsy companies, is delighted to announce that it has signed a contract with a new customer, Crescendo Biologics Limited (Crescendo). Crescendo is a UK-based, clinical stage immuno-oncology company with an extensive proprietary...

In a significant update to its existing policies when it comes to conducting clinical trials so as to support an accelerated approval for oncology as well as other life-saving therapies, the FDA is planning a preference for randomised controlled...